Insilico Medicine
Insilico Medicine offers generative AI software for drug discovery, including PandaOmics, Chemistry42, and inClinico modules.
UnknownVerified
INNo preview available
What is Insilico Medicine?
Insilico Medicine has developed a comprehensive drug discovery software suite that empowers researchers with advanced capabilities. The suite includes PandaOmics for omics data analysis, Chemistry42 for molecular generation, and inClinico for clinical trial prediction, among other tools.
Key features
- PandaOmics for Target Identification
- Chemistry42 for Compound Design
- inClinico for Clinical Trial Prediction
- PandaOmics
- Chemistry42
- inClinico
- Target discovery with PandaOmics
- Molecule generation with Chemistry42
- Clinical trial prediction with inClinico
Use cases
- Target Identification
- Compound Design
- Clinical Trial Prediction
- Drug discovery
- Scientific research
- Sustainability
- Drug target identification
- Molecular design for therapeutics
- Clinical trial simulation